Aralez Pharmaceuticals (ARZ) Stock Price Down 4.5%

Aralez Pharmaceuticals Inc (TSE:ARZ) shares fell 4.5% during mid-day trading on Monday . The company traded as low as C$2.14 and last traded at C$2.14. 20,154 shares changed hands during mid-day trading, a decline of 60% from the average session volume of 49,863 shares. The stock had previously closed at C$2.24.

The company has a market capitalization of $113.74 and a price-to-earnings ratio of -1.33.

ILLEGAL ACTIVITY NOTICE: “Aralez Pharmaceuticals (ARZ) Stock Price Down 4.5%” was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at

About Aralez Pharmaceuticals

Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.

Receive News & Ratings for Aralez Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply